Results 51 to 60 of about 1,013,786 (315)

An Unconventional Regimen of Carboplatin and Paclitaxel in Metastatic Colorectal Carcinosarcoma: A Case Report and Review of Literature

open access: yesCurrent Oncology, 2023
Colorectal carcinosarcoma is an exceedingly rare subtype of colorectal cancer that displays the histological and molecular features of both mesenchymal and epithelial tumors.
Changsu Lawrence Park   +3 more
doaj   +1 more source

Ovarian Sex Cord Stromal Tumors in Children and Adolescents—The European Standard Clinical Practice Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference.
Dominik T. Schneider   +15 more
wiley   +1 more source

Apatinib Treatment in Metastatic Gastrointestinal Stromal Tumor

open access: yesFrontiers in Oncology, 2019
Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. The clinical management of patients with metastatic GISTs is exceptionally challenging due to their poor prognosis.
Zhaolun Cai, Xin Chen, Bo Zhang, Dan Cao
doaj   +1 more source

An unusual presentation of neonatal rhabdomyosarcoma: a case report

open access: yesFrontiers in Pediatrics, 2023
A full-term infant with an unremarkable prenatal course presented at birth with a large midline facial mass and smaller masses in the head and neck. In addition, multiple diffuse flesh-colored nodules spread along all the upper and lower limbs.
Danielle Strah   +7 more
doaj   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine   +17 more
wiley   +1 more source

ПРАКТИЧЕСКИЕ РЕКОМЕНДАЦИИ ПО ПРЕДОТВРАЩЕНИЮ И КОРРЕКЦИИ ПОБОЧНЫХ ЭФФЕКТОВ СУНИТИНИБА [PDF]

open access: yes, 2010
At present Sunitinib is the drug of choice in the treatment of metastatic renal cell carcinoma. In some cases complications due to the use of the drug make it to be unreasonably discontinued, which potentially affects the results of therapy.
S. L. Gutorov   +3 more
core   +1 more source

Exercise as part of survivorship care in metastatic breast cancer: protocol for the randomized EMBody trial

open access: yesBMC Cancer
Background Exercise is associated with improved survival, physical functioning, treatment tolerability, and quality of life in early-stage breast cancer. These same endpoints matter in metastatic breast cancer (MBC).
Martha A. Cancilla   +12 more
doaj   +1 more source

STIM1, ORAI1, and KDM2B in circulating tumor cells (CTCs) isolated from prostate cancer patients

open access: yesFrontiers in Cell and Developmental Biology
Introduction: Previous publications have shown that STIM1, ORAI1, and KDM2B, are implicated in Ca2+ signaling and are highly expressed in various cancer subtypes including prostate cancer.
Argyro Roumeliotou   +5 more
doaj   +1 more source

Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers

open access: yesMedical Sciences, 2019
Esophageal cancer (EC) is among the most frequent and deadly cancers around the world. While esophageal adenocarcinoma (EAC) has one of the fastest-growing incidences amongst cancers in the US, it also has one of the lowest survival rates due to the ...
Adam Barsouk   +4 more
doaj   +1 more source

Metastatic testicular cancer presenting with hematuria and flank pain

open access: yesUrology Annals, 2022
Testicular cancer (TC) represents 1% of male neoplasms and 5% of urological tumors. Most of seminoma patients and about 55% of patients with nonseminoma TC have stage I disease at diagnosis.
Daniel Antonio Gonzalez-Padilla   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy